| Filed On | Filing |
|---|---|
| 31 May 2023 |
Form 4/A: Dayno Jeffrey M., Director
Granted 125,000 Stock Option |
| 04 Sep 2020 |
Form 4/A: Marshman Fund Trust Ii, 10% owner
Received 3,379,881 shares by conversion |
| 04 Sep 2020 |
Form 4/A: Serafin Andrew, Chief Business Officer
Received 33,693 shares by conversion |
| 04 Sep 2020 |
Form 4/A: Valor Iv Pharma Holdings, Llc, 10% owner and 8 others
Received 10,372,697 shares by conversion |
| 04 Sep 2020 |
Form 4/A: Novo Holdings A/S, 10% owner
Received 3,622,470 shares by conversion |
Loading...